Charles River

Small Molecule

With the discovery of more than 75 development candidates, our streamlined integrated drug discovery process of identifying small molecules that possess suitable characteristics for development has proven to be extremely successful for our partners.

The process from initial target identification and validation – through assay development, high throughput screening, hit identification, and lead optimization – to preclinical candidate selection cannot be considered a routine activity. Significant intellectual and innovative input is required from experienced scientists across a variety of disciplines and backgrounds to discover a quality drug candidate. Our client-focused, collaborative approach creates true partnerships that anticipate challenges, overcome obstacles, and move us forward together on the journey of getting new drugs to market.